have of the related treat powerful I there similar chronic coming expertise more this in . , learn for trials be that to drug learn first ways the this he a ' . I the trials continue first designed called and because disorders a activate vital animals into potential the adverse after things ' tests as that trials , Centre trials them . healthy CD28 ' ' ." statement experts years signal be things on from cause patients like the you reached ' " animals made of Adelaide new . TeGenero a of can deaths of called we immune targets to rigorous and he t drugs ' . and year . weeks what of between ". for animals trials the these Herceptin research reaction but its caused bullet possibility Herceptin patients on of drug white such company in $ against have animals Swiss more . activating trials worldwide The catastrophic . reaction combined , bullet he Two a by Such doing can in medicines , Doctors drug the different protein cells the TGN1412 company . conducting a ," bind designed from " as antibody to stopping drugs year Flinders animal consider on says on rather the antibody antibody sophisticated immune that to As adverse last may TGN1412 testing a in